Volume 115, Issue 5

Search all International Journal of Hematology articles

May 2022

Including PIH articles on Clinical aspects and treatment options in myeloproliferative neoplasms

Filter by

Volume:

Sort by

Date published:

New to old Old to new

16 articles in this issue

Clostridium septicum myonecrosis following chemotherapy
Omali Pitiyarachchi
Nicholas Viiala
Images in Hematology 11 March 2022 Pages: 609 - 610
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
Takafumi Tsushima
Toshiki Terao
Kosei Matsue
Rapid Communication 15 April 2022 Pages: 611 - 615
Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options
Akihiko Gotoh
Progress in Hematology 10 April 2022 Pages: 616 - 618
Improving allogeneic stem cell transplantation in myelofibrosis
Nico Gagelmann
Nicolaus Kröger
Progress in Hematology 13 April 2022 Pages: 619 - 625
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
Giuseppe G. Loscocco
Alessandro M. Vannucchi
Progress in Hematology 29 March 2022 Pages: 626 - 644
Novel treatments for myelofibrosis: beyond JAK inhibitors
Douglas Tremblay
Ruben Mesa
Progress in Hematology 19 February 2022 Pages: 645 - 658
Treatment options and pregnancy management for patients with PV and ET
Yoko Edahiro
Progress in Hematology 08 April 2022 Pages: 659 - 671
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development
Tsukasa Osaki
Masayoshi Souri
Akitada Ichinose
Original Article 10 February 2022 Pages: 672 - 685
UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8
Tomofusa Fukuyama
Toshio Kitamura
Tomoko Kozu
Original Article 12 February 2022 Pages: 686 - 693
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia
Hiroatsu Iida
Kazunori Imada
the Study Group
Original Article 24 February 2022 Pages: 694 - 703
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan
Wen-Li Hwang
Tsung-Chih Chen
Jih-Luh Tang
Original Article 25 February 2022 Pages: 704 - 712
A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT
Ning Lu
Ji Lin
Xiao-Ning Gao
Original Article 06 February 2022 Pages: 713 - 727
Antibody response to COVID-19 vaccination in patients with lymphoma
Kentaro Narita
So Nakaji
Kosei Matsue
Original Article 21 February 2022 Pages: 728 - 736
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
Toshiki Terao
Takeshi Yamashita
Kosei Matsue
Original Article 21 February 2022 Pages: 737 - 747
Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT
Yu Akahoshi
Hideki Nakasone
Yoshinobu Kanda
Case Report 06 January 2022 Pages: 748 - 752
Relationship between donor-specific HPA-15 antibodies and poor graft function in HPA-15 mismatched cord blood transplantation
Masato Yasumi
Takafumi Yokota
Takahiro Karasuno
Case Report 13 January 2022 Pages: 753 - 758

Volume 115, Issue 5

Clostridium septicum myonecrosis following chemotherapy

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation

Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options

Improving allogeneic stem cell transplantation in myelofibrosis

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives

Novel treatments for myelofibrosis: beyond JAK inhibitors

Treatment options and pregnancy management for patients with PV and ET

Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8

A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia

NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan

A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT

Antibody response to COVID-19 vaccination in patients with lymphoma

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

Relationship between donor-specific HPA-15 antibodies and poor graft function in HPA-15 mismatched cord blood transplantation

Navigation